Supernus Pharmaceuticals Inc (SUPN)
SG&A Expense Growth
6.76%
Quarterly · Period ending:
SUPN SG&A Expense Growth
Latest reported6.76%period ending
Latest reported6.76%period ending
SUPN Quarterly SG&A Growth (QoQ) (0.00% → 6.76%)
Latest values, visible window
High-resolution chart · PNG
SUPN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.7618% | |
| 2.2739% | |
| -31.8837% | |
| 92.0642% | |
| 4.0103% | |
| 13.2668% | |
| 13.8431% | |
| -18.8012% | |
| -0.7074% | |
| 6.4393% | |
| -1.7146% | |
| -4.7037% | |
| 1.3844% | |
| 15.7154% | |
| -34.1382% | |
| 11.7819% | |
| 11.0735% | |
| -11.0837% | |
| 41.2358% | |
| 3.591% | |
| 13.1441% | |
| 9.1599% | |
| 3.3786% | |
| 13.2154% | |
| 15.5933% | |
| 16.4843% | |
| -9.196% | |
| -1.0911% | |
| -2.9071% | |
| -2.5731% | |
| 2.8318% | |
| 1.9827% | |
| 8.8144% | |
| 9.137% | |
| -17.2958% | |
| 16.3835% | |
| 24.2227% | |
| -2.8119% | |
| 13.1646% | |
| -1.7074% | |
| 3.8196% | |
| 6.764% | |
| 2.9083% | |
| -1.8684% | |
| 20.2763% | |
| 7.6812% | |
| 3.8921% | |
| -11.4294% | |
| 11.7191% | |
| 15.135% | |
| 4.1245% | |
| 19.6987% | |
| -9.7465% | |
| 55.8383% | |
| 113.1043% | |
| -12.2713% | |
| 70.2713% | |
| -2.0467% | |
| 85.543% | |
| -20.7916% | |
| 8.4717% | |
| 3.2975% | |
| 0% | |
| 0% | |
| 0% |